Search clinical trials for: IIGI GLP-1

Total 15951 results

Sapporo Medical University
Merck Sharp & Dohme LLC

Completed

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Coronary Artery Disease

Japan
Zydus Lifesciences Limited

Completed

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers (ZYD1)

Type 2 Diabetes Mellitus

India
University of Pennsylvania

Completed

GLP 1 for Intraoperative Glycemic Control (GLP)

Hyperglycemia | Hypoglycemia

United States
Rigshospitalet, Denmark
Department of Cardiovascular and Renal Research, University of Southern Denmark

Completed

Acute Effects of GLP-1 on Renal Hemodynamics (GLP1RRBF)

The GLP-1-mediated Gut-kidney Axis

Denmark
King's College London

Recruiting

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Obesity | Diabetes Mellitus | Mental Health Issue

United Kingdom
Azienda Ospedaliero-Universitaria Consorziale Policlinico...

Completed

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Diabetes Mellitus, Type 2

Italy
Jeppe Skov
Novo Nordisk A/S

Completed

GLP-1: Acute Effects on Kidney Function in Healthy Men

Kidney Functional

Denmark
University of Maryland, Baltimore

Active, not recruiting

GLP-1 and Hypoglycemia

Type 2 Diabetes Mellitus

United States
Radboud University Medical Center
Rijnstate Hospital

Recruiting

Visualizing Beta Cells After Bariatric Surgery (GLP1-bar)

Type 2 Diabetes Mellitus

Netherlands
Zealand University Hospital
University of Copenhagen; Glostrup University Hospital, Copenhagen

Unknown

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

Healthy

Denmark
University Hospital, Gentofte, Copenhagen

Completed

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

Obesity | Incretin Action

Denmark
Rigshospitalet, Denmark
Novo Nordisk A/S; University of Copenhagen

Completed

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

Hypoglycaemia

Denmark
Jose Seijas Amigo

Completed

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY. (SEVERAL)

Quality of Life | Diabetes Mellitus, Type 2 | Weight Loss | Safety Issues

Spain
Diabetes Care Center of Nanjing Military Command

Unknown

Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

Type 2 Diabetes

China
Christina Kruuse

Recruiting

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke (EGRABIS1)

Ischemic Stroke

Denmark
University Hospital, Gentofte, Copenhagen

Completed

Physiology of GIP(1-30)NH2 in Humans (GA-11)

Glucose Metabolism Disorders

Denmark
Katarina Kos
University of Exeter

Terminated

Incretin and KATP Channels

Healthy Subjects

United Kingdom
Centre Hospitalier Universitaire Dijon

Completed

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging (LICAS-MR)

Type II Diabetes

France
Mikkel Christensen

Completed

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

Type 1 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Recruiting

The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes (GIPHYPO)

Hypoglycemia | Type1diabetes | Type 1 Diabetes

Denmark
The University of Texas Health Science Center at...

Recruiting

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Hypoglycemia | Post Bariatricsurgery

United States
Katarina Kos
Diabetes UK

Completed

The Microvascular Function of GLP-1 and Its Analogues

Obesity | Type 2 Diabetes

United Kingdom
Elahi, Dariush, PhD
Massachusetts General Hospital; National Institute on Aging (NIA); ICON plc

Unknown

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man (LVKGR)

Insulin Resistance

United States
GeneOne Life Science, Inc.

Active, not recruiting

GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)

COVID-19 | Healthy

Puerto Rico, United States
Christina Kruuse

Completed

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers (EGRABINS1)

Stroke

Denmark
Medical University of Graz

Completed

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

Hyperglycemia | Diabetes Mellitus Type 2

Austria
Zealand Pharma

Completed

A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Healthy

Germany
David Dalessio

Unknown

Effect of GLP-1 on Postprandial Lipid Metabolism

Heart Disease

United States
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

GIP Receptor Antagonist Studies in Humans (GA-1)

Glucose Metabolism

Denmark
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Treating PCOS With Semaglutide vs Active Lifestyle Intervention (TEAL)

PCOS | NAFLD | Adolescent Obesity

United States
University of Minho

Completed

A Study Protocol for an Online Intervention to Promote School Engagement

Cerebral Palsy

Portugal
The Affiliated Hospital of Xuzhou Medical University

Recruiting

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Type 2 Diabetes Mellitus | Susceptibility, Genetic

China
University of Surrey
Sanofi

Completed

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

Type 2 Diabetes

United Kingdom
Shanghai Jiao Tong University School of Medicine

Completed

Effect of Protein-Restricted Diet on Nitrogen Balance and Residual Renal Function in Peritoneal Dialysis (PD) Patients

Peritoneal Dialysis | Chronic Kidney Disease
Steno Diabetes Center Copenhagen

Unknown

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

Effect of Glucagon-like Peptide 2 on Gallbladder Motility

Denmark
PegBio Co., Ltd.

Completed

Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects (PB119)

Type 2 Diabetes Mellitus (T2DM)

China
PegBio Co., Ltd.

Completed

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

China
GlyPharma Therapeutics
VectivBio AG

Completed

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Short Bowel Syndrome

Denmark
Novavax

Completed

A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1

Avian Influenza

Australia
Papworth Hospital NHS Foundation Trust

Completed

Cardioprotective Effects of GLP-1 and Their Mechanisms

Angina Pectoris

United Kingdom
Diabeteszentrum Bad Lauterberg im Harz

Completed

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Type 2 Diabetes

Germany
Papworth Hospital NHS Foundation Trust

Unknown

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting (DREAM GLP-1)

Right Coronary Artery Percutaneous Coronary Intervention | Right Ventricular Diastolic Dysfunction

United Kingdom
GlyPharma Therapeutics
VectivBio AG

Completed

Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency

SBS - Short Bowel Syndrome

Denmark
University of Nottingham

Completed

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle (Incretin)

Sarcopenia

United Kingdom
Baylor College of Medicine
George Washington University; Children's National Research Institute

Completed

Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant

Hookworm Infection | Hookworm Disease

United States
Johns Hopkins University

Terminated

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

Bariatric Surgery

United States
Medicago
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Completed

Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

Canada
University of Minnesota
Cystic Fibrosis Foundation

Recruiting

Semaglutide in CFRD

Cystic Fibrosis | Cystic Fibrosis-related Diabetes

United States
Vanderbilt-Ingram Cancer Center

Recruiting

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Diabetes Mellitus | Cancer

United States
Institut de Recherches Internationales Servier

Active, not recruiting

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

Glioma

United States

Search clinical trials for: IIGI GLP-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations